Identification of targetable molecular alterations in the NCI-COG Pediatric MATCH trial. Randomization of dose-reduced subcutaneous interleukin-2 (scIL2) in maintenance immunotherapy (IT) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results